SEARCH

SEARCH BY CITATION

References

  • 1
    Nardin JM, Weeks A, Carroli G. Umbilical vein injection for management of retained placenta (review). Cochrane Database Syst Rev. 2011;5:CD001337.
  • 2
    Weeks AD, Mirembe FM. Editorial. The retained placenta—new insights into an old problem. Eur J Obstet Gynecol Reprod Biol. 2002;102:10910.
  • 3
    World Health Organization. The prevention and management of postpartum haemorrhage: report of a technical working group. 3–6 July 1989. Geneva: WHO, 1989.
  • 4
    Nordstrom L, Fogelstam K, Fridman G, Larsson A, Rydhstroem H. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol. 1997;104:7816.
  • 5
    Van Stralen G, van Roosmalen J. Regarding Roger MS, Yen PM, Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol Scand. 2007;86:764.
  • 6
    Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:8892.
  • 7
    Chong YS, Chua S, Shen L, Arulkumaran S. Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery. Eur J Obstet Gynecol Reprod Biol. 2004;113:1918.
  • 8
    Farmacotherapeutisch kompas. http://www.cvzkompassen.nl; July 2008.
  • 9
    Vogel D, Burkhardt T, Rentsch K, Schweer H, Watzer B, Zimmermann R, et al. Misoprostol versus methylergometrine: pharmacokinetics in human milk. Am J Obstet Gynecol. 2004;191:216873.
  • 10
    Abdel Aleem H. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol 2003;108:258.
  • 11
    Deneux-Tharaux C, MacFarlane A, Winter C, Zang WH, Alexander S, Bouvier-Colle MH, the EUPHRATES group. Policies for manual removal of placenta at vaginal delivery: variations in timing within Europe. Br J Obstet Gynaecol. 2009;116:11924.
  • 12
    Chedraui PA, Insuati DF. Intravenous nitroglycerin in the management of retained placenta. Gynecol Obstet Invest. 2003;56:614.
  • 13
    Bullarbo M, Tjugum J, Ekerhovd E. Sublingual nitroglycerin for management of retained placenta. Int J Gynecol Obstet. 2005;91:28832.
  • 14
    Visaloyaputra S, Prechapanich J, Suwanvichai S, Yimyam S, Permpolprasert L, Suksopee P. Intravenous nitroglycerin for controlled cord traction in the management of retained placenta. Int J Gynecol Obstet. 2011;112:1036.
  • 15
    Van Beekhuizen HJ, De Groot ANJA, De Boo T, Burger D, Jansen N, Lotgering F. Sulprostone reduces the need for manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol. 2006;194:22650.
  • 16
    Lim PS, Singh S, Lee A, Yassin MAJM. Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta? Arch Gynecol Obstet. 2011;248:10739.
  • 17
    Harara R, Hanafi S, Zidan MSA, Alberry M. Intraumbilical injection of three uterotonics in the management of retained placenta. J Obstet Gynecol Res. 2011;9:12037.
  • 18
    Rogers MS, Yuen PM, Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol Scand. 2007;86:4854.
  • 19
    Abdel-Aleem H, Abdel-Aleem MA, Shaaban OM. Tocolysis for management of retained placenta. Cochrane Database Syst Rev. 2011;1:CD007708.
  • 20
    Soltani H, Poulose TA, Hutchon DR. Placental cord drainage after vaginal delivery as part of the management of the third stage of labour (review). Cochrane Database Syst Rev. 2011;9:CD004665.